letrozole

The drug is used for hormone therapy in postmenopausal women with various forms of breast cancer (adjuvant therapy, treatment of advanced forms, or preparation for surgical intervention).

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: GenePharm SA

The drug is used for hormonal therapy in postmenopausal women with various forms of breast cancer (adjuvant therapy in early stages, treatment of advanced cancer, or therapy after recurrence).

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: PJSC Pharmaceutical Plant Egis (Responsible for batch release)

The drug is used for hormone therapy in postmenopausal women with various forms of breast cancer (at early stages, in advanced cancer, or after recurrence), as well as for neoadjuvant therapy in cases where chemotherapy is not suitable.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Novartis Pharma Stein AG (Manufacturing of unpackaged products, primary and secondary packaging, quality control)

The drug is used for hormone therapy in postmenopausal women with various forms of breast cancer (adjuvant therapy, treatment of advanced forms after recurrence, or neoadjuvant therapy).

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Hetero Labs Limited

The drug is used for hormone therapy in postmenopausal women with various forms of breast cancer (adjuvant therapy, treatment of advanced cancer, neoadjuvant therapy).

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Eugia Pharma Specialities Limited

The drug is used for hormone therapy in postmenopausal women with various forms of breast cancer (at early stages, in advanced cancer, or after recurrence), as well as for neoadjuvant therapy.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Farmak JSC

The drug is used for hormone therapy in postmenopausal women with various forms of breast cancer (adjuvant therapy, treatment of advanced forms after recurrence, or neoadjuvant therapy).

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Synthon Hispania, S.L.

The drug is used for hormonal therapy in postmenopausal women with various forms of breast cancer (adjuvant therapy, treatment of advanced forms after recurrence, or first-line therapy). It may also be used as neoadjuvant therapy in cases where chemotherapy is not suitable for the patient.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Syndan Pharma S.R.L.

The drug is prescribed for hormonal therapy in postmenopausal women with various forms of breast cancer (at early stages, in advanced cancer, after recurrence, or as preparation for surgery).

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Synthon Hispania, S.L.

The drug is used for hormonal therapy in postmenopausal women with various forms of breast cancer (at early stages, in advanced cancer, or after recurrence).

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: ASTRAFARM LLC

The drug is used for hormonal therapy in postmenopausal women with various forms of breast cancer (at early stages, in advanced cancer, or after recurrence), as well as for neoadjuvant therapy.

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Genepharm S.A.

The drug is used for hormonal therapy in postmenopausal women with various forms of breast cancer (adjuvant therapy, treatment of advanced forms, or neoadjuvant therapy).

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Intas Pharmaceuticals Limited (responsible for manufacturing in bulk, primary packaging, secondary packaging)

The drug is used for hormone therapy in postmenopausal women with various forms of breast cancer (at early stages, in advanced cancer, after recurrence, or as an adjunct to tamoxifen therapy).

Form: tablets, film-coated

ATC: L02BG04

Manufacturer: Teva Pharmaceutical Industries Ltd. (manufacturing, primary and secondary packaging, quality control, batch release)